Mereo BioPharma Group (MREO)

MREO trades at $1.74, 13.0% below the near-term max pain of $2 expiring Aug 15, 2025 (0 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($0.5-$7), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for MREO shows a downward trend from 7 to 0.5, indicating bearish sentiment or hedging activity. The 284% spread signals divergent expectations across timeframes. Levels distributed around 1.74. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.